Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX2-1
|
ENSG00000136352.13 | NK2 homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_36990374_36990607 | NKX2-1 | 136 | 0.943212 | 0.64 | 6.5e-02 | Click! |
chr14_36989210_36989422 | NKX2-1 | 23 | 0.943031 | 0.48 | 1.9e-01 | Click! |
chr14_36990794_36990945 | NKX2-1 | 515 | 0.724164 | 0.47 | 2.1e-01 | Click! |
chr14_36989834_36989985 | NKX2-1 | 245 | 0.877429 | 0.28 | 4.6e-01 | Click! |
chr14_36988822_36989041 | NKX2-1 | 33 | 0.881591 | -0.13 | 7.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_71591322_71591805 | 0.39 |
ENSG00000221264 |
. |
323 |
0.83 |
chr20_19739352_19739650 | 0.35 |
AL121761.2 |
Uncharacterized protein |
822 |
0.67 |
chr14_78668483_78668908 | 0.34 |
ENSG00000199454 |
. |
24431 |
0.22 |
chr9_114554047_114554198 | 0.33 |
C9orf84 |
chromosome 9 open reading frame 84 |
3090 |
0.29 |
chr7_20254919_20255070 | 0.32 |
MACC1 |
metastasis associated in colon cancer 1 |
2019 |
0.4 |
chr17_45334887_45335241 | 0.31 |
ENSG00000238419 |
. |
1722 |
0.26 |
chr15_99344237_99344527 | 0.31 |
ENSG00000264480 |
. |
16727 |
0.24 |
chr6_35393359_35394053 | 0.31 |
FANCE |
Fanconi anemia, complementation group E |
26432 |
0.15 |
chr11_92441050_92441201 | 0.30 |
ENSG00000239086 |
. |
21456 |
0.24 |
chr18_24155354_24155632 | 0.29 |
ENSG00000252846 |
. |
11269 |
0.22 |
chr4_157888355_157888628 | 0.29 |
PDGFC |
platelet derived growth factor C |
3564 |
0.27 |
chr8_23397789_23397996 | 0.29 |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
11319 |
0.16 |
chr20_1460805_1460958 | 0.28 |
ENSG00000266085 |
. |
8314 |
0.14 |
chr7_72974638_72974971 | 0.28 |
BCL7B |
B-cell CLL/lymphoma 7B |
2472 |
0.22 |
chr2_65087186_65087345 | 0.28 |
ENSG00000199964 |
. |
25974 |
0.15 |
chr1_86038271_86038452 | 0.28 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
5572 |
0.2 |
chr11_9778479_9778630 | 0.27 |
SBF2-AS1 |
SBF2 antisense RNA 1 |
1285 |
0.44 |
chr17_42425530_42425884 | 0.27 |
GRN |
granulin |
2200 |
0.16 |
chr7_152010807_152011572 | 0.27 |
KMT2C |
lysine (K)-specific methyltransferase 2C |
66085 |
0.11 |
chr9_33354750_33355149 | 0.26 |
ENSG00000200544 |
. |
2077 |
0.27 |
chr11_75735939_75736309 | 0.26 |
UVRAG |
UV radiation resistance associated |
41644 |
0.15 |
chr17_438204_438582 | 0.26 |
RP5-1029F21.4 |
|
12013 |
0.17 |
chr17_40562098_40562486 | 0.26 |
ENSG00000221020 |
. |
11265 |
0.11 |
chr7_134938605_134938973 | 0.26 |
STRA8 |
stimulated by retinoic acid 8 |
22058 |
0.17 |
chr12_54655635_54656068 | 0.26 |
RP11-968A15.2 |
|
548 |
0.55 |
chr21_40683413_40684326 | 0.26 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
1627 |
0.24 |
chr2_69309476_69309763 | 0.26 |
ANTXR1 |
anthrax toxin receptor 1 |
6884 |
0.22 |
chr1_109931574_109931829 | 0.26 |
SORT1 |
sortilin 1 |
4278 |
0.19 |
chr5_149189745_149189896 | 0.25 |
PPARGC1B |
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
22758 |
0.18 |
chr1_9145986_9146241 | 0.25 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
2389 |
0.23 |
chr5_126898357_126898508 | 0.25 |
PRRC1 |
proline-rich coiled-coil 1 |
45084 |
0.18 |
chr11_74347920_74348157 | 0.25 |
POLD3 |
polymerase (DNA-directed), delta 3, accessory subunit |
1621 |
0.37 |
chr5_72511846_72512133 | 0.25 |
TMEM174 |
transmembrane protein 174 |
42967 |
0.14 |
chr6_147234985_147235152 | 0.25 |
STXBP5-AS1 |
STXBP5 antisense RNA 1 |
1953 |
0.49 |
chr8_26123678_26123924 | 0.24 |
PPP2R2A |
protein phosphatase 2, regulatory subunit B, alpha |
25206 |
0.23 |
chr17_42872109_42872587 | 0.24 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
9986 |
0.14 |
chr1_235104740_235105149 | 0.24 |
ENSG00000239690 |
. |
65011 |
0.12 |
chr2_219597745_219597964 | 0.24 |
TTLL4 |
tubulin tyrosine ligase-like family, member 4 |
4443 |
0.16 |
chr1_10958313_10958477 | 0.24 |
C1orf127 |
chromosome 1 open reading frame 127 |
49532 |
0.12 |
chr15_92034111_92034262 | 0.24 |
SV2B |
synaptic vesicle glycoprotein 2B |
265086 |
0.02 |
chr5_171530999_171531150 | 0.24 |
ENSG00000266671 |
. |
23094 |
0.19 |
chr1_95119284_95119435 | 0.24 |
ENSG00000263526 |
. |
92097 |
0.08 |
chr10_81109102_81109275 | 0.24 |
PPIF |
peptidylprolyl isomerase F |
1774 |
0.38 |
chr22_19074070_19074357 | 0.24 |
AC004471.9 |
|
34829 |
0.09 |
chr2_38404404_38404678 | 0.24 |
ENSG00000199603 |
. |
29984 |
0.19 |
chr5_138753028_138753179 | 0.23 |
DNAJC18 |
DnaJ (Hsp40) homolog, subfamily C, member 18 |
7634 |
0.1 |
chr19_1796326_1796477 | 0.23 |
ATP8B3 |
ATPase, aminophospholipid transporter, class I, type 8B, member 3 |
15222 |
0.09 |
chr11_34443753_34443957 | 0.23 |
CAT |
catalase |
16617 |
0.22 |
chr12_32655690_32655927 | 0.23 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
657 |
0.77 |
chr17_54236463_54236752 | 0.23 |
ANKFN1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
5736 |
0.33 |
chr1_29575738_29576111 | 0.23 |
ENSG00000221550 |
. |
4271 |
0.18 |
chr1_28879167_28879368 | 0.23 |
TRNAU1AP |
tRNA selenocysteine 1 associated protein 1 |
330 |
0.8 |
chr4_140099443_140099664 | 0.23 |
ELF2 |
E74-like factor 2 (ets domain transcription factor) |
1181 |
0.4 |
chr17_71064314_71064465 | 0.23 |
SLC39A11 |
solute carrier family 39, member 11 |
21514 |
0.23 |
chr16_81534432_81534869 | 0.23 |
CMIP |
c-Maf inducing protein |
5696 |
0.3 |
chr1_49083295_49083518 | 0.23 |
AGBL4 |
ATP/GTP binding protein-like 4 |
63168 |
0.14 |
chr3_171579285_171579488 | 0.23 |
TMEM212 |
transmembrane protein 212 |
18080 |
0.18 |
chr6_142699159_142699742 | 0.23 |
GPR126 |
G protein-coupled receptor 126 |
11999 |
0.29 |
chr12_64261703_64261854 | 0.23 |
RP11-274J7.2 |
|
10789 |
0.17 |
chr6_37023589_37023822 | 0.22 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
11098 |
0.2 |
chr1_235035137_235035288 | 0.22 |
ENSG00000239690 |
. |
4721 |
0.3 |
chr5_146889795_146890041 | 0.22 |
DPYSL3 |
dihydropyrimidinase-like 3 |
299 |
0.94 |
chr8_130691624_130691889 | 0.22 |
GSDMC |
gasdermin C |
107378 |
0.06 |
chr15_66910964_66911559 | 0.22 |
RP11-321F6.1 |
HCG2003567; Uncharacterized protein |
36733 |
0.12 |
chr20_11790867_11791018 | 0.22 |
ENSG00000222281 |
. |
8797 |
0.29 |
chr6_7130248_7130425 | 0.22 |
RREB1 |
ras responsive element binding protein 1 |
9142 |
0.22 |
chr1_175560414_175560565 | 0.22 |
TNR-IT1 |
TNR intronic transcript 1 (non-protein coding) |
34535 |
0.23 |
chr10_54286609_54286760 | 0.22 |
RP11-556E13.1 |
|
34181 |
0.24 |
chr6_109063657_109063820 | 0.22 |
FOXO3 |
forkhead box O3 |
86189 |
0.09 |
chr1_61650059_61650312 | 0.21 |
RP4-802A10.1 |
|
59780 |
0.14 |
chr7_93868977_93869198 | 0.21 |
COL1A2 |
collagen, type I, alpha 2 |
154786 |
0.04 |
chr4_120024366_120024563 | 0.21 |
MYOZ2 |
myozenin 2 |
32475 |
0.19 |
chr5_133837543_133837821 | 0.21 |
ENSG00000207222 |
. |
1707 |
0.32 |
chr11_10350303_10350459 | 0.21 |
AMPD3 |
adenosine monophosphate deaminase 3 |
11163 |
0.16 |
chr7_127858076_127858330 | 0.21 |
ENSG00000207705 |
. |
10279 |
0.19 |
chr1_165831561_165831763 | 0.21 |
UCK2 |
uridine-cytidine kinase 2 |
33145 |
0.15 |
chr9_130302299_130302610 | 0.21 |
FAM129B |
family with sequence similarity 129, member B |
28913 |
0.13 |
chr12_3226541_3226699 | 0.21 |
TSPAN9-IT1 |
TSPAN9 intronic transcript 1 (non-protein coding) |
32343 |
0.17 |
chr17_33568770_33569141 | 0.21 |
RP11-799D4.4 |
|
1027 |
0.35 |
chr2_153277819_153278036 | 0.20 |
FMNL2 |
formin-like 2 |
86176 |
0.1 |
chr2_47262098_47262362 | 0.20 |
AC093732.1 |
|
5433 |
0.21 |
chr1_208381209_208381624 | 0.20 |
PLXNA2 |
plexin A2 |
36249 |
0.24 |
chr13_40684091_40684242 | 0.20 |
ENSG00000207458 |
. |
116798 |
0.07 |
chr3_172036187_172036338 | 0.20 |
AC092964.1 |
Uncharacterized protein |
2044 |
0.36 |
chr1_95296795_95296987 | 0.20 |
SLC44A3 |
solute carrier family 44, member 3 |
10685 |
0.21 |
chr18_9704973_9705544 | 0.20 |
RAB31 |
RAB31, member RAS oncogene family |
2904 |
0.31 |
chr9_111826033_111826184 | 0.20 |
ENSG00000207698 |
. |
17530 |
0.14 |
chr2_43191638_43192077 | 0.20 |
ENSG00000207087 |
. |
126775 |
0.05 |
chr12_49626134_49626329 | 0.20 |
TUBA1C |
tubulin, alpha 1c |
4522 |
0.14 |
chr16_85244563_85244846 | 0.20 |
CTC-786C10.1 |
|
39822 |
0.17 |
chr8_57595398_57595566 | 0.20 |
RP11-17A4.2 |
|
193825 |
0.03 |
chr17_38171762_38172321 | 0.20 |
CSF3 |
colony stimulating factor 3 (granulocyte) |
301 |
0.83 |
chr14_89824555_89824893 | 0.20 |
RP11-356K23.2 |
|
3320 |
0.22 |
chr1_157373506_157373754 | 0.20 |
FCRL5 |
Fc receptor-like 5 |
148550 |
0.04 |
chr7_42277787_42277938 | 0.20 |
GLI3 |
GLI family zinc finger 3 |
1204 |
0.66 |
chr3_134317870_134318272 | 0.20 |
EPHB1 |
EPH receptor B1 |
16136 |
0.21 |
chr17_1548050_1548254 | 0.20 |
SCARF1 |
scavenger receptor class F, member 1 |
886 |
0.4 |
chr5_139727515_139728049 | 0.19 |
HBEGF |
heparin-binding EGF-like growth factor |
1566 |
0.26 |
chr13_107137363_107137514 | 0.19 |
EFNB2 |
ephrin-B2 |
50024 |
0.17 |
chr3_185479152_185479525 | 0.19 |
ENSG00000265470 |
. |
6354 |
0.24 |
chr17_43253672_43253834 | 0.19 |
RP13-890H12.2 |
|
4802 |
0.11 |
chr9_119714349_119714500 | 0.19 |
ENSG00000265662 |
. |
146862 |
0.04 |
chr15_99226253_99226598 | 0.19 |
IGF1R |
insulin-like growth factor 1 receptor |
24635 |
0.2 |
chr7_16697056_16697503 | 0.19 |
BZW2 |
basic leucine zipper and W2 domains 2 |
3569 |
0.24 |
chr14_21574185_21574440 | 0.19 |
ZNF219 |
zinc finger protein 219 |
1431 |
0.25 |
chr1_178911938_178912211 | 0.19 |
RALGPS2 |
Ral GEF with PH domain and SH3 binding motif 2 |
56860 |
0.12 |
chr5_124201652_124202095 | 0.19 |
ZNF608 |
zinc finger protein 608 |
117373 |
0.06 |
chr2_153324557_153324708 | 0.19 |
FMNL2 |
formin-like 2 |
132881 |
0.05 |
chr5_14154020_14154339 | 0.19 |
TRIO |
trio Rho guanine nucleotide exchange factor |
10350 |
0.32 |
chr1_77748942_77749155 | 0.19 |
AK5 |
adenylate kinase 5 |
284 |
0.93 |
chr7_2680395_2680583 | 0.19 |
TTYH3 |
tweety family member 3 |
4677 |
0.21 |
chr2_70699360_70699623 | 0.19 |
TGFA-IT1 |
TGFA intronic transcript 1 (non-protein coding) |
3864 |
0.2 |
chr20_44538606_44538964 | 0.19 |
PLTP |
phospholipid transfer protein |
791 |
0.42 |
chr2_172380569_172381265 | 0.19 |
CYBRD1 |
cytochrome b reductase 1 |
1328 |
0.53 |
chr11_88256352_88256580 | 0.19 |
GRM5-AS1 |
GRM5 antisense RNA 1 |
11550 |
0.29 |
chr6_64516560_64517136 | 0.19 |
RP11-59D5__B.2 |
|
119 |
0.98 |
chr12_22436696_22436847 | 0.19 |
ST8SIA1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
34791 |
0.21 |
chr6_137587453_137587604 | 0.19 |
IFNGR1 |
interferon gamma receptor 1 |
46942 |
0.17 |
chr10_33653913_33654108 | 0.18 |
NRP1 |
neuropilin 1 |
28820 |
0.23 |
chr1_242494290_242494441 | 0.18 |
PLD5 |
phospholipase D family, member 5 |
118362 |
0.06 |
chr15_75418307_75418680 | 0.18 |
ENSG00000252722 |
. |
4486 |
0.2 |
chr2_87016233_87016699 | 0.18 |
CD8A |
CD8a molecule |
1482 |
0.41 |
chr2_14775111_14775564 | 0.18 |
AC011897.1 |
Uncharacterized protein |
122 |
0.97 |
chr18_10594479_10594630 | 0.18 |
RP11-856M7.1 |
|
67376 |
0.1 |
chr2_235933793_235934065 | 0.18 |
SH3BP4 |
SH3-domain binding protein 4 |
30445 |
0.26 |
chr4_143883337_143883532 | 0.18 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
114849 |
0.07 |
chr8_126510706_126510857 | 0.18 |
ENSG00000266452 |
. |
53974 |
0.15 |
chr21_39875635_39875873 | 0.18 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
5347 |
0.34 |
chr9_93959973_93960173 | 0.18 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
164104 |
0.04 |
chr4_40623166_40623743 | 0.18 |
RBM47 |
RNA binding motif protein 47 |
8427 |
0.27 |
chr1_31350251_31350496 | 0.18 |
SDC3 |
syndecan 3 |
1214 |
0.42 |
chr2_20311558_20311709 | 0.18 |
RP11-644K8.1 |
|
59738 |
0.09 |
chr6_106329312_106329592 | 0.18 |
ENSG00000200198 |
. |
22796 |
0.27 |
chr12_1702754_1702905 | 0.18 |
FBXL14 |
F-box and leucine-rich repeat protein 14 |
502 |
0.82 |
chr8_29420044_29420195 | 0.18 |
RP4-676L2.1 |
|
209432 |
0.02 |
chr1_49243286_49243470 | 0.18 |
BEND5 |
BEN domain containing 5 |
788 |
0.77 |
chr7_23503511_23503662 | 0.18 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
6500 |
0.18 |
chr7_100781001_100781597 | 0.18 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
10920 |
0.1 |
chr8_29492885_29493176 | 0.18 |
RP4-676L2.1 |
|
282343 |
0.01 |
chr20_17972943_17973101 | 0.18 |
MGME1 |
mitochondrial genome maintenance exonuclease 1 |
23264 |
0.13 |
chr7_41727697_41728013 | 0.18 |
INHBA-AS1 |
INHBA antisense RNA 1 |
5659 |
0.22 |
chr2_197853357_197853508 | 0.18 |
ANKRD44 |
ankyrin repeat domain 44 |
11794 |
0.26 |
chr12_50447359_50447620 | 0.18 |
ASIC1 |
acid-sensing (proton-gated) ion channel 1 |
3842 |
0.15 |
chr2_204513967_204514120 | 0.17 |
CD28 |
CD28 molecule |
57155 |
0.14 |
chr1_28653417_28653596 | 0.17 |
MED18 |
mediator complex subunit 18 |
2043 |
0.28 |
chr7_99970452_99970794 | 0.17 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
445 |
0.66 |
chr7_138664896_138665077 | 0.17 |
KIAA1549 |
KIAA1549 |
1078 |
0.59 |
chr11_63388800_63389118 | 0.17 |
RP11-697H9.3 |
|
5179 |
0.15 |
chr20_52355039_52355190 | 0.17 |
ENSG00000238468 |
. |
69817 |
0.12 |
chr19_41936846_41937128 | 0.17 |
B3GNT8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
2352 |
0.14 |
chr6_47276047_47276198 | 0.17 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
1519 |
0.54 |
chr1_56991345_56991645 | 0.17 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
53746 |
0.16 |
chr1_61718931_61719082 | 0.17 |
NFIA |
nuclear factor I/A |
99116 |
0.08 |
chr7_22899009_22899286 | 0.17 |
ENSG00000221740 |
. |
2915 |
0.31 |
chr22_41762881_41763188 | 0.17 |
TEF |
thyrotrophic embryonic factor |
303 |
0.87 |
chr3_184355166_184355357 | 0.17 |
MAGEF1 |
melanoma antigen family F, 1 |
74575 |
0.09 |
chr2_70368551_70369209 | 0.17 |
C2orf42 |
chromosome 2 open reading frame 42 |
40247 |
0.11 |
chr16_74777388_74777539 | 0.17 |
FA2H |
fatty acid 2-hydroxylase |
2296 |
0.28 |
chr21_40211048_40211199 | 0.17 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
29563 |
0.22 |
chr5_6705329_6705555 | 0.17 |
PAPD7 |
PAP associated domain containing 7 |
9276 |
0.26 |
chr8_6372842_6373023 | 0.17 |
ANGPT2 |
angiopoietin 2 |
47633 |
0.16 |
chr16_1742334_1742485 | 0.17 |
HN1L |
hematological and neurological expressed 1-like |
6908 |
0.09 |
chr4_15452943_15453218 | 0.17 |
CC2D2A |
coiled-coil and C2 domain containing 2A |
18409 |
0.16 |
chr6_56820926_56821126 | 0.17 |
BEND6 |
BEN domain containing 6 |
856 |
0.52 |
chr5_37249784_37249952 | 0.17 |
C5orf42 |
chromosome 5 open reading frame 42 |
338 |
0.89 |
chr7_134477490_134477641 | 0.17 |
CALD1 |
caldesmon 1 |
13136 |
0.28 |
chr18_53156534_53156869 | 0.17 |
RP11-619L19.2 |
|
2705 |
0.26 |
chr20_52556645_52557141 | 0.17 |
AC005220.3 |
|
194 |
0.96 |
chr11_119563178_119563367 | 0.17 |
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
35991 |
0.13 |
chr2_208734859_208735279 | 0.17 |
AC083900.1 |
|
430 |
0.86 |
chr5_102294298_102294449 | 0.17 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
9092 |
0.31 |
chr1_46598395_46598546 | 0.17 |
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
4 |
0.96 |
chr3_185463874_185464186 | 0.17 |
ENSG00000265470 |
. |
21662 |
0.19 |
chr8_124642901_124643058 | 0.17 |
CTD-2552K11.2 |
|
16514 |
0.17 |
chr3_25515158_25515309 | 0.17 |
RARB |
retinoic acid receptor, beta |
15432 |
0.26 |
chr11_103553300_103553882 | 0.17 |
ENSG00000264200 |
. |
167043 |
0.04 |
chr6_37279555_37279706 | 0.17 |
RNF8 |
ring finger protein 8, E3 ubiquitin protein ligase |
42118 |
0.11 |
chr6_150209605_150209756 | 0.17 |
RAET1E-AS1 |
RAET1E antisense RNA 1 |
1559 |
0.24 |
chr10_81104566_81104717 | 0.17 |
PPIF |
peptidylprolyl isomerase F |
2586 |
0.3 |
chr10_116474114_116474265 | 0.17 |
ABLIM1 |
actin binding LIM protein 1 |
29775 |
0.21 |
chr10_80328339_80328521 | 0.17 |
ENSG00000223243 |
. |
181929 |
0.03 |
chr7_115995833_115995984 | 0.17 |
ENSG00000216076 |
. |
9910 |
0.21 |
chr22_44704942_44705093 | 0.17 |
KIAA1644 |
KIAA1644 |
3714 |
0.31 |
chrX_48858096_48858311 | 0.17 |
GRIPAP1 |
GRIP1 associated protein 1 |
442 |
0.68 |
chr20_61334808_61334959 | 0.17 |
NTSR1 |
neurotensin receptor 1 (high affinity) |
5306 |
0.14 |
chr3_105089117_105089308 | 0.17 |
ALCAM |
activated leukocyte cell adhesion molecule |
3025 |
0.42 |
chr8_23610347_23610498 | 0.17 |
ENSG00000216123 |
. |
15736 |
0.17 |
chr7_5674087_5674709 | 0.17 |
FSCN1 |
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
40081 |
0.12 |
chr8_122176471_122176664 | 0.17 |
ENSG00000221644 |
. |
22565 |
0.27 |
chr9_96263559_96263710 | 0.17 |
FAM120A |
family with sequence similarity 120A |
30803 |
0.14 |
chr16_74764278_74764475 | 0.17 |
FA2H |
fatty acid 2-hydroxylase |
10791 |
0.18 |
chr4_140958813_140959347 | 0.16 |
RP11-392B6.1 |
|
90089 |
0.09 |
chr10_21812025_21812176 | 0.16 |
SKIDA1 |
SKI/DACH domain containing 1 |
2511 |
0.2 |
chr17_72747231_72747488 | 0.16 |
MIR3615 |
microRNA 3615 |
2308 |
0.15 |
chr10_80850413_80850863 | 0.16 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
21846 |
0.22 |
chr16_66521179_66521358 | 0.16 |
AC132186.1 |
CDNA FLJ27243 fis, clone SYN08134; Uncharacterized protein |
1521 |
0.27 |
chr9_75080014_75080202 | 0.16 |
TMC1 |
transmembrane channel-like 1 |
56609 |
0.14 |
chr6_123112103_123112308 | 0.16 |
SMPDL3A |
sphingomyelin phosphodiesterase, acid-like 3A |
1734 |
0.38 |
chr1_33462562_33463087 | 0.16 |
RP1-117O3.2 |
|
10148 |
0.14 |
chr16_12707264_12707435 | 0.16 |
CTD-3037G24.3 |
|
2448 |
0.33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.2 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.3 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.0 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.0 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.0 | GO:0009169 | nucleoside monophosphate catabolic process(GO:0009125) purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.2 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.0 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.3 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 0.3 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.0 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |